Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ACE2,Angiotensin-converting enzyme 2,27250,862,0.65 [0.55-0.78],1.958611127620568e-06
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ACP5,Tartrate-resistant acid phosphatase type 5,27884,885,0.59 [0.48-0.72],2.0099117851635058e-07
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ACRV1,Acrosomal protein SP-10,23511,713,0.76 [0.60-0.96],0.0217006153647737
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ACTA2,"Actin, aortic smooth muscle",27250,862,0.77 [0.65-0.91],0.0023158342897019
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ACVRL1,Serine/threonine-protein kinase receptor R3,27523,875,0.72 [0.54-0.97],0.030577824699755
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ACY1,Aminoacylase-1,27761,877,0.80 [0.72-0.90],0.0002189491821348
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ADA2,Adenosine deaminase 2,27581,866,1.23 [1.04-1.44],0.0136580687287406
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,23511,713,0.75 [0.58-0.97],0.028842672740941
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,28096,889,1.44 [1.08-1.93],0.0141451680193576
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,27636,879,0.79 [0.70-0.89],0.0001307061271159
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,27250,862,0.70 [0.56-0.88],0.0024908086868795
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,23511,713,0.70 [0.55-0.88],0.0022489050149844
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,27858,887,0.76 [0.65-0.88],0.0001694503527199
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ADGRB3,Adhesion G protein-coupled receptor B3,27523,875,0.75 [0.61-0.92],0.0054271672991896
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ADGRD1,Adhesion G-protein coupled receptor D1,23684,720,0.65 [0.52-0.82],0.0001919870433041
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ADGRF5,Adhesion G protein-coupled receptor F5,24197,736,0.70 [0.54-0.91],0.0074683201555026
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ADGRG1,Adhesion G-protein coupled receptor G1,27636,879,1.24 [1.06-1.46],0.0086899785431716
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ADH1B,All-trans-retinol dehydrogenase,23684,720,0.87 [0.78-0.98],0.0189258033619577
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ADM,Pro-adrenomedullin,27991,889,0.67 [0.53-0.83],0.0004312314348561
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,AFM,Afamin,24244,735,0.56 [0.37-0.85],0.0065418262875942
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,AGR2,Anterior gradient protein 2 homolog,26840,861,0.92 [0.86-0.98],0.0131243350661094
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,AGR3,Anterior gradient protein 3,27060,861,0.83 [0.73-0.94],0.0031182422506717
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,AGRN,Agrin,27898,881,0.77 [0.62-0.95],0.017498167460109
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",27671,881,0.84 [0.75-0.94],0.0027191609099669
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,AMBP,Protein AMBP,27953,888,0.52 [0.37-0.73],0.0001820873761194
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ANGPTL1,Angiopoietin-related protein 1,27385,865,0.67 [0.54-0.84],0.0005868091785611
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ANGPTL7,Angiopoietin-related protein 7,27991,889,0.81 [0.69-0.97],0.0179852712172899
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ANPEP,Aminopeptidase N,27805,872,0.62 [0.49-0.80],0.0001825562320729
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,APCS,Serum amyloid P-component,24025,727,0.77 [0.63-0.95],0.0143067746534635
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,27894,887,0.88 [0.79-0.98],0.0198657644328073
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,APOM,Apolipoprotein M,27806,874,0.60 [0.47-0.78],8.410603575030952e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,AREG,Amphiregulin,27636,879,0.87 [0.77-0.98],0.017730210202836
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ART3,Ecto-ADP-ribosyltransferase 3,27854,874,0.74 [0.60-0.91],0.0046126534750833
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ASGR1,Asialoglycoprotein receptor 1,27565,878,0.70 [0.55-0.88],0.0020187852890853
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,B2M,Beta-2-microglobulin,24244,735,1.30 [1.03-1.62],0.0248367100412265
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23574,720,0.73 [0.59-0.91],0.0039696877048622
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,27107,863,0.85 [0.76-0.96],0.007013472014543
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,BCL2L15,Bcl-2-like protein 15,23511,713,0.86 [0.74-0.99],0.0379160124189507
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24061,735,0.82 [0.68-0.98],0.0315681886128818
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,BGLAP,Osteocalcin,24196,735,0.89 [0.81-0.97],0.0066249620106673
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,23429,723,0.73 [0.54-0.98],0.0361719725879622
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,BLNK,B-cell linker protein,23511,713,0.74 [0.59-0.92],0.0070973047140511
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,BMPER,BMP-binding endothelial regulator protein,23684,720,0.69 [0.48-0.99],0.0437337049490355
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,BOLA1,BolA-like protein 1,23415,719,0.81 [0.70-0.94],0.0066191587317442
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,BRD2,Bromodomain-containing protein 2,23415,719,0.76 [0.60-0.97],0.03041184591364
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,BSG,Basigin,28001,887,0.56 [0.39-0.80],0.0014973913055642
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,BTN1A1,Butyrophilin subfamily 1 member A1,24015,734,1.35 [1.17-1.55],2.3718875535900184e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,BTN3A2,Butyrophilin subfamily 3 member A2,27713,881,0.79 [0.66-0.94],0.0094562822167371
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,23635,720,0.77 [0.66-0.90],0.0009137303164468
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CA11,Carbonic anhydrase-related protein 11,27107,863,0.79 [0.62-0.99],0.0409033844190964
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CA4,Carbonic anhydrase 4,28096,889,0.39 [0.29-0.51],5.0164451582028456e-11
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CA5A,"Carbonic anhydrase 5A, mitochondrial",27250,862,0.90 [0.83-0.97],0.0067456245828522
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CA9,Carbonic anhydrase 9,27991,889,0.82 [0.69-0.96],0.0134689270025471
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CALCA,Calcitonin,27513,877,0.84 [0.74-0.95],0.00502002902634
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CASP4,Caspase-4,23743,724,1.05 [1.01-1.10],0.0240439258269125
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CASQ2,Calsequestrin-2,23429,723,0.82 [0.69-0.98],0.0273084669971787
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CBLN4,Cerebellin-4,27991,889,1.30 [1.06-1.60],0.0118009963931843
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CCDC80,Coiled-coil domain-containing protein 80,27761,877,0.63 [0.51-0.78],1.516965654177806e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23574,720,0.80 [0.70-0.91],0.0009995108828844
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CCL11,Eotaxin,28047,888,0.74 [0.63-0.86],0.0001804633512053
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CCL15,C-C motif chemokine 15,28096,889,0.74 [0.64-0.86],9.395818336683452e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CCL16,C-C motif chemokine 16,28096,889,0.78 [0.69-0.87],1.623713882653145e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CCL21,C-C motif chemokine 21,27898,881,0.83 [0.70-0.99],0.0346332919503532
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CCL22,C-C motif chemokine 22,27502,867,0.84 [0.73-0.96],0.0115073229454612
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CCL27,C-C motif chemokine 27,27761,877,0.85 [0.76-0.94],0.0023267551605334
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CCL4,C-C motif chemokine 4,27808,877,0.87 [0.77-0.97],0.0130169534326581
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CCN1,CCN family member 1,27588,878,0.92 [0.85-0.99],0.0301786465329069
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CD160,CD160 antigen,28047,888,1.55 [1.34-1.79],4.301957928525855e-09
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CD207,C-type lectin domain family 4 member K,27172,862,0.75 [0.63-0.90],0.0015744816991188
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CD244,Natural killer cell receptor 2B4,28047,888,1.49 [1.17-1.91],0.0014501842684288
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CD27,CD27 antigen,27858,887,1.25 [1.05-1.49],0.0131917212207235
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CD276,CD276 antigen,27763,878,0.75 [0.63-0.90],0.0019917144939488
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CD300LG,CMRF35-like molecule 9,27762,876,0.76 [0.63-0.91],0.0028466150194909
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CD36,Platelet glycoprotein 4,23511,713,0.82 [0.69-0.98],0.0254017881530172
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CD48,CD48 antigen,27850,880,1.46 [1.16-1.85],0.0012670173686799
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CD55,Complement decay-accelerating factor,26774,844,0.70 [0.53-0.93],0.0148546059560448
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CD59,CD59 glycoprotein,26730,847,0.61 [0.43-0.88],0.0075310786420669
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CD5L,CD5 antigen-like,24101,731,1.21 [1.02-1.44],0.02554655154406
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CD86,T-lymphocyte activation antigen CD86,24071,732,1.31 [1.01-1.70],0.0430349353895805
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CD8A,T-cell surface glycoprotein CD8 alpha chain,27998,890,1.53 [1.33-1.75],1.1985570729554911e-09
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CDH15,Cadherin-15,27946,889,0.73 [0.61-0.88],0.0007517443465604
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CDH2,Cadherin-2,27761,877,0.77 [0.64-0.93],0.0059173276663315
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CDH22,Cadherin-22,23743,724,0.72 [0.54-0.95],0.022067991618613
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CDHR2,Cadherin-related family member 2,27636,879,0.81 [0.74-0.88],2.1746563073308804e-06
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,27812,880,0.59 [0.46-0.74],1.1456797803880585e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,27813,887,0.78 [0.61-1.00],0.0460278803434806
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24071,732,1.10 [1.01-1.21],0.0340864397537561
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24071,732,0.82 [0.67-1.00],0.0456534463353295
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,26749,857,0.81 [0.72-0.90],0.0001867160123456
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24196,735,0.77 [0.63-0.93],0.0072811567494243
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CERT,Ceramide transfer protein,27078,865,0.89 [0.80-1.00],0.0452078014416262
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CES1,Liver carboxylesterase 1,27818,879,0.84 [0.76-0.92],0.0002925704283852
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CES2,Cocaine esterase,27636,879,0.87 [0.76-0.98],0.0268078739613891
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CFC1,Cryptic protein,27107,863,0.86 [0.74-1.00],0.0477712043663105
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CFI,Complement factor I,24244,735,0.65 [0.44-0.94],0.0235924108828609
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CGREF1,Cell growth regulator with EF hand domain protein 1,27761,877,0.79 [0.68-0.93],0.0053178922144701
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CHAD,Chondroadherin,23684,720,0.82 [0.70-0.96],0.0119152205101046
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CHCHD6,MICOS complex subunit MIC25,24061,735,0.74 [0.55-0.98],0.0373444237378313
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CHGA,Chromogranin-A,24196,735,0.84 [0.76-0.94],0.0028910728372766
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CHGB,Secretogranin-1,27894,888,0.74 [0.62-0.88],0.0007505707814901
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CHM,Rab proteins geranylgeranyltransferase component A 1,23520,713,0.86 [0.75-0.98],0.0265954680367969
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CILP,Cartilage intermediate layer protein 1,24196,735,0.85 [0.74-0.98],0.0250037705280768
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CLC,Galectin-10,27720,877,1.11 [1.01-1.21],0.023596775882631
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CLEC14A,C-type lectin domain family 14 member A,27762,876,0.77 [0.62-0.96],0.0212796965480454
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CLEC2L,C-type lectin domain family 2 member L,23520,713,0.79 [0.66-0.94],0.0092416787435688
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CLEC4A,C-type lectin domain family 4 member A,27713,881,0.77 [0.64-0.92],0.0045335167546606
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CLEC4C,C-type lectin domain family 4 member C,27713,881,1.16 [1.00-1.34],0.047685650503079
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CLEC5A,C-type lectin domain family 5 member A,27672,873,0.75 [0.59-0.95],0.01948976784612
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",27513,877,0.92 [0.86-0.99],0.0255434605822404
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CNTN1,Contactin-1,28096,889,0.67 [0.52-0.85],0.0011266795164567
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CNTN2,Contactin-2,27991,889,0.84 [0.73-0.97],0.0208157555606963
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,COL15A1,Collagen alpha-1(XV) chain,24196,735,0.72 [0.52-0.99],0.0401770433664867
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,COL18A1,Collagen alpha-1(XVIII) chain,27871,881,0.68 [0.51-0.90],0.0077629977997144
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,COL1A1,Collagen alpha-1(I) chain,28096,889,0.57 [0.44-0.75],4.230673770856784e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,COL3A1,Collagen alpha-1(III) chain,24196,735,0.71 [0.51-0.99],0.0413501904888664
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,COL5A1,Collagen alpha-1(V) chain,23684,720,0.72 [0.58-0.90],0.0031010685529722
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,COL6A3,Collagen alpha-3(VI) chain,28096,889,0.76 [0.62-0.94],0.0102115294311239
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,COL9A1,Collagen alpha-1(IX) chain,27713,881,1.18 [1.01-1.39],0.042850474436385
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",23574,720,0.78 [0.64-0.96],0.016197117845248
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CPA4,Carboxypeptidase A4,23200,708,0.75 [0.63-0.90],0.0016222998480143
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CPB2,Carboxypeptidase B2,24192,734,0.61 [0.43-0.87],0.0060670863827709
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CPE,Carboxypeptidase E,27785,886,0.83 [0.70-0.98],0.0259056225230397
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CPM,Carboxypeptidase M,27865,888,0.83 [0.69-1.00],0.0483105823554158
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",23511,713,0.59 [0.44-0.80],0.000603934053464
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CPXM2,Inactive carboxypeptidase-like protein X2,24197,736,0.63 [0.45-0.87],0.0059300151721909
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CR2,Complement receptor type 2,27854,874,1.29 [1.12-1.49],0.0005254840795791
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CRELD1,Protein disulfide isomerase CRELD1,23684,720,0.75 [0.61-0.92],0.0069818433885167
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CRH,Corticoliberin,27060,862,1.09 [1.01-1.18],0.0208328073383044
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CRIP2,Cysteine-rich protein 2,27565,878,0.71 [0.59-0.86],0.000494550233406
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CRTAM,Cytotoxic and regulatory T-cell molecule,27565,878,1.66 [1.45-1.89],1.0813350853348892e-13
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CRYM,Ketimine reductase mu-crystallin,23415,719,0.87 [0.78-0.97],0.0139694883924029
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CST1,Cystatin-SN,20981,642,0.88 [0.81-0.97],0.0090146714956891
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CST3,Cystatin-C,27813,871,0.73 [0.56-0.94],0.0150483821109634
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CST5,Cystatin-D,27288,870,0.79 [0.70-0.90],0.0002528415819096
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CST6,Cystatin-M,27020,855,0.80 [0.69-0.93],0.0034281689737708
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CTHRC1,Collagen triple helix repeat-containing protein 1,24196,735,0.51 [0.39-0.69],6.429595495961319e-06
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CTSE,Cathepsin E,23684,720,0.81 [0.70-0.95],0.006909834767242
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CTSL,Cathepsin L1,27761,877,0.64 [0.49-0.85],0.0019281942921828
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CTSV,Cathepsin L2,27911,889,0.77 [0.66-0.89],0.0005430018838993
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CX3CL1,Fractalkine,27565,878,0.75 [0.62-0.93],0.0069097900724663
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CXADR,Coxsackievirus and adenovirus receptor,27713,881,0.78 [0.68-0.90],0.0005075949728201
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CXCL10,C-X-C motif chemokine 10,27898,881,1.11 [1.01-1.22],0.0251132850136256
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CXCL16,C-X-C motif chemokine 16,28049,888,0.38 [0.29-0.51],6.452385968970005e-11
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CXCL17,C-X-C motif chemokine 17,28047,888,0.79 [0.68-0.92],0.0021223616454044
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CXCL9,C-X-C motif chemokine 9,27898,881,1.16 [1.06-1.27],0.0011915200990141
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,CYB5R2,NADH-cytochrome b5 reductase 2,23783,728,0.84 [0.73-0.97],0.0179614616960118
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,DCUN1D1,DCN1-like protein 1,23415,719,0.88 [0.78-0.98],0.0254680069199021
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,DCXR,L-xylulose reductase,27858,887,0.85 [0.74-0.96],0.0124881954247289
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",27636,879,0.86 [0.74-1.00],0.0451757654300911
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,DDX25,ATP-dependent RNA helicase DDX25,23520,713,0.76 [0.60-0.95],0.0144758429110287
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,DEFA1_DEFA1B,Neutrophil defensin 1,27184,855,0.86 [0.75-0.99],0.0348565665667235
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,DIPK2B,Divergent protein kinase domain 2B,23684,720,0.60 [0.45-0.82],0.0010339741749969
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,DKK3,Dickkopf-related protein 3,28096,889,0.71 [0.57-0.89],0.0033504185131552
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,DNAJC9,DnaJ homolog subfamily C member 9,24071,732,0.90 [0.82-1.00],0.0459560456300638
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,DNER,Delta and Notch-like epidermal growth factor-related receptor,27718,880,0.51 [0.39-0.67],1.4790053452076838e-06
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,DPP10,Inactive dipeptidyl peptidase 10,27713,881,0.71 [0.58-0.87],0.0009398521195021
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,DTX2,Probable E3 ubiquitin-protein ligase DTX2,23520,713,1.13 [1.02-1.25],0.0163410059947616
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,DTX3,Probable E3 ubiquitin-protein ligase DTX3,27636,879,0.69 [0.52-0.92],0.0117971795148445
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,EBI3_IL27,Interleukin-27,27942,889,1.25 [1.03-1.53],0.0237949272720196
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ECE1,Endothelin-converting enzyme 1,27078,865,0.80 [0.67-0.97],0.0214614845402531
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24197,736,0.86 [0.77-0.97],0.0142931158625978
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,EDA2R,Tumor necrosis factor receptor superfamily member 27,27991,889,0.62 [0.51-0.76],4.675002792744673e-06
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,27250,862,0.69 [0.57-0.83],0.0001128495791476
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,EDN1,Endothelin-1,23574,720,0.74 [0.57-0.97],0.0303501746656645
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,EFNA1,Ephrin-A1,27720,875,1.38 [1.07-1.79],0.0134319968395125
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,EFNB2,Ephrin-B2,23520,713,0.83 [0.73-0.96],0.0102655347193677
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,EIF5A,Eukaryotic translation initiation factor 5A-1,27208,867,0.78 [0.62-0.98],0.0298800407458002
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ELN,Elastin,24197,736,0.63 [0.50-0.80],0.0001234146309597
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ENO3,Beta-enolase,23574,720,0.85 [0.73-0.98],0.0280677198265699
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,28096,889,1.33 [1.08-1.64],0.0070396216265904
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ENSA,Alpha-endosulfine,24061,735,0.80 [0.69-0.94],0.0068197144390845
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,EPCAM,Epithelial cell adhesion molecule,27768,877,0.89 [0.83-0.96],0.0014212161777955
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ERBB2,Receptor tyrosine-protein kinase erbB-2,27858,887,0.69 [0.53-0.89],0.0037861704695727
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ESAM,Endothelial cell-selective adhesion molecule,28096,889,0.79 [0.64-0.98],0.0286472009280832
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,F10,Coagulation factor X,24209,732,0.72 [0.53-0.98],0.0357084382598727
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,F3,Tissue factor,27827,884,0.76 [0.60-0.97],0.0270703744282433
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,F7,Coagulation factor VII,27811,871,0.80 [0.65-1.00],0.0457165217871964
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,F9,Coagulation factor IX,27806,874,0.46 [0.33-0.66],1.9766710755733853e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FAM20A,Pseudokinase FAM20A,24197,736,0.64 [0.49-0.84],0.0012459557491952
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FAM3B,Protein FAM3B,27636,879,0.83 [0.70-0.98],0.0322340212952028
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FAM3C,Protein FAM3C,27716,877,0.75 [0.60-0.94],0.0143531386671069
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FASLG,Tumor necrosis factor ligand superfamily member 6,28047,888,1.35 [1.13-1.62],0.0009982809218422
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FBLN2,Fibulin-2,24196,735,0.73 [0.56-0.94],0.0146186002107899
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24158,739,0.70 [0.50-0.97],0.0314978799272075
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,27107,863,0.73 [0.65-0.82],7.906260061044255e-08
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FCRL5,Fc receptor-like protein 5,27762,876,1.25 [1.11-1.41],0.0002806560712498
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FCRL6,Fc receptor-like protein 6,27713,881,1.31 [1.18-1.45],1.8293432129283945e-07
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FGF12,Fibroblast growth factor 12,23511,713,0.76 [0.62-0.94],0.011189065906344
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FGF19,Fibroblast growth factor 19,27898,881,0.87 [0.80-0.95],0.0016559252713421
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FGF21,Fibroblast growth factor 21,27942,889,0.90 [0.85-0.95],0.0002817961767615
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FGF5,Fibroblast growth factor 5,27208,867,0.75 [0.61-0.93],0.0076279599076996
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FGFR2,Fibroblast growth factor receptor 2,27858,887,0.50 [0.36-0.68],1.7189145698370653e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FGL1,Fibrinogen-like protein 1,24209,732,0.86 [0.76-0.97],0.0134670474262735
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FLT3LG,Fms-related tyrosine kinase 3 ligand,28047,888,0.73 [0.60-0.89],0.0017674056083486
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FOLH1,Glutamate carboxypeptidase 2,23511,713,0.92 [0.85-1.00],0.0391320559726318
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FOXO3,Forkhead box protein O3,27107,863,0.93 [0.87-1.00],0.0453374137073795
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FSHB,Follitropin subunit beta,23574,720,0.86 [0.76-0.98],0.0231658143830197
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,27998,890,0.68 [0.59-0.79],5.830548708225948e-07
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GAD1,Glutamate decarboxylase 1,23319,718,0.69 [0.51-0.93],0.0153185673438012
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GAS6,Growth arrest-specific protein 6,27907,881,0.67 [0.52-0.86],0.0014895204951363
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GAST,Gastrin,24141,733,0.90 [0.83-0.97],0.0060658100986827
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GBP1,Guanylate-binding protein 1,24099,731,1.18 [1.05-1.33],0.005945498566758
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GBP6,Guanylate-binding protein 6,23429,723,0.83 [0.69-1.00],0.0487950477482827
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",27636,879,1.23 [1.02-1.48],0.0310743413789857
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GDF15,Growth/differentiation factor 15,28096,889,0.71 [0.60-0.85],0.0002166212703423
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GDNF,Glial cell line-derived neurotrophic factor,27078,865,0.68 [0.57-0.82],3.629799407863708e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GFRA1,GDNF family receptor alpha-1,27942,889,0.70 [0.54-0.89],0.0045420822557048
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GFRA3,GDNF family receptor alpha-3,27479,876,0.72 [0.57-0.91],0.0056000869585582
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GGA1,ADP-ribosylation factor-binding protein GGA1,27078,865,0.88 [0.80-0.96],0.0066288006592874
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GGT1,Glutathione hydrolase 1 proenzyme,27720,875,0.72 [0.62-0.85],9.253431699056543e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GH1,Somatotropin,27716,877,0.95 [0.92-0.99],0.0071544309896789
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GHR,Growth hormone receptor,23684,720,0.76 [0.59-0.99],0.0424846793935532
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GLA,Alpha-galactosidase A,23636,720,0.60 [0.48-0.75],9.298873091235751e-06
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,23520,713,0.84 [0.72-0.99],0.0321952899668043
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,26904,854,0.88 [0.81-0.96],0.0027058072224249
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GPA33,Cell surface A33 antigen,27636,879,0.93 [0.88-0.98],0.0038115428000081
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GPHA2,Glycoprotein hormone alpha-2,24071,732,0.80 [0.68-0.95],0.0112111504267805
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GPR37,Prosaposin receptor GPR37,27250,862,0.88 [0.79-0.98],0.0159233523883951
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GPRC5C,G-protein coupled receptor family C group 5 member C,24061,735,0.81 [0.69-0.95],0.0109800946121143
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GRP,Gastrin-releasing peptide,23574,720,0.83 [0.71-0.96],0.0143918435376241
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GSTA1,Glutathione S-transferase A1,27720,877,0.92 [0.84-1.00],0.0400761729705078
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GUCA2A,Guanylin,27634,869,0.71 [0.57-0.87],0.0012828603436838
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GUSB,Beta-glucuronidase,27884,885,0.83 [0.74-0.93],0.001798843796415
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GZMA,Granzyme A,28047,888,1.41 [1.16-1.70],0.0004402505815602
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,GZMH,Granzyme H,27250,862,1.12 [1.03-1.22],0.0073094280661601
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,HAVCR1,Hepatitis A virus cellular receptor 1,27953,888,0.82 [0.73-0.92],0.0010465583660924
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,HBZ,Hemoglobin subunit zeta,24197,736,1.09 [1.02-1.18],0.0149875022331411
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,HEG1,Protein HEG homolog 1,23684,720,0.53 [0.39-0.73],5.536568269463681e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,HEPH,Hephaestin,24197,736,0.72 [0.54-0.97],0.0321568607072651
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,HGF,Hepatocyte growth factor,28047,888,0.70 [0.58-0.84],0.000205584980225
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,HIP1R,Huntingtin-interacting protein 1-related protein,24098,732,0.82 [0.67-0.99],0.0437576298654431
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,HJV,Hemojuvelin,24158,739,0.78 [0.65-0.94],0.0076449216692677
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,27636,879,0.64 [0.54-0.75],1.1957683320535272e-07
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,23511,713,0.76 [0.58-1.00],0.047318482141878
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,HSBP1,Heat shock factor-binding protein 1,23574,720,0.91 [0.84-0.99],0.0216263248001865
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,27533,866,0.74 [0.55-0.99],0.044033179974834
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,HTR1B,5-hydroxytryptamine receptor 1B,23415,719,0.81 [0.66-0.99],0.0358914644910555
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,HYOU1,Hypoxia up-regulated protein 1,28096,889,0.72 [0.53-0.98],0.0345334914075569
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ICAM4,Intercellular adhesion molecule 4,27713,881,1.14 [1.01-1.29],0.0407717713159009
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,IDO1,"Indoleamine 2,3-dioxygenase 1",23574,720,1.18 [1.05-1.33],0.0057872850541125
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,IFNG,Interferon gamma,27208,867,1.08 [1.02-1.14],0.0072875268810329
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,IFNL2,Interferon lambda-2,23415,719,0.87 [0.76-0.99],0.0315610903174821
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24196,735,0.69 [0.51-0.93],0.0144780823082101
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,IGFBPL1,Insulin-like growth factor-binding protein-like 1,27761,877,0.75 [0.61-0.92],0.0050976332339112
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,IGHMBP2,DNA-binding protein SMUBP-2,23429,723,0.85 [0.73-0.98],0.0248629791070297
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,IGSF9,Protein turtle homolog A,24197,736,0.85 [0.77-0.94],0.0018203423875761
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,IL12A_IL12B,Interleukin-12,27636,879,1.11 [1.02-1.21],0.019411108718282
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,IL12B,Interleukin-12 subunit beta,28047,888,1.15 [1.02-1.31],0.0254896758904222
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,IL15,Interleukin-15,27713,881,0.75 [0.61-0.93],0.0080933573255594
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,IL1R1,Interleukin-1 receptor type 1,27720,875,0.67 [0.49-0.91],0.0108809845416549
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,IL1R2,Interleukin-1 receptor type 2,27720,875,0.63 [0.46-0.88],0.0069308687533976
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,IL1RAP,Interleukin-1 receptor accessory protein,27762,876,1.17 [1.00-1.36],0.0453196952758721
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,IL22,Interleukin-22,24061,735,1.19 [1.06-1.32],0.0025166631745908
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,IL25,Interleukin-25,23240,715,0.68 [0.54-0.85],0.0008076904609484
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,IL4R,Interleukin-4 receptor subunit alpha,27713,881,0.80 [0.66-0.96],0.0186047831964517
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,IL6ST,Interleukin-6 receptor subunit beta,27761,877,0.47 [0.32-0.68],9.327237385263884e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,INSL3,Insulin-like 3,24141,733,0.87 [0.77-0.98],0.0264815625400555
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,26695,854,0.78 [0.65-0.93],0.0064032440093111
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ISM1,Isthmin-1,27713,881,0.80 [0.68-0.93],0.0051762640871458
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ITGA11,Integrin alpha-11,27713,881,1.46 [1.20-1.76],0.0001026453976507
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ITGAM,Integrin alpha-M,27762,876,1.63 [1.33-2.00],2.9399881258629265e-06
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ITGB2,Integrin beta-2,27580,871,1.68 [1.33-2.11],9.815762610893544e-06
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ITM2A,Integral membrane protein 2A,27713,881,0.81 [0.73-0.91],0.0002554960772534
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ITPA,Inosine triphosphate pyrophosphatase,23429,723,0.86 [0.77-0.97],0.013905039301492
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,KDR,Vascular endothelial growth factor receptor 2,27858,887,0.69 [0.55-0.86],0.0013481661132278
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,KEL,Kell blood group glycoprotein,27078,865,0.79 [0.66-0.96],0.0180495486877264
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,KLHL41,Kelch-like protein 41,24158,739,0.81 [0.69-0.95],0.0081436813941743
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,KLK13,Kallikrein-13,27155,864,0.85 [0.73-1.00],0.0489814262380409
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,KLK14,Kallikrein-14,27991,889,0.70 [0.60-0.80],5.886483798420773e-07
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,KLK15,Kallikrein-15,24023,732,0.79 [0.68-0.93],0.0037731644381296
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,KLK3,Prostate-specific antigen,24196,735,0.84 [0.72-0.96],0.0125980056025238
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,KLK4,Kallikrein-4,27991,889,0.85 [0.77-0.95],0.0027198302501029
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,KLK7,Kallikrein-7,23050,698,0.77 [0.62-0.95],0.0154315372751017
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,KLRB1,Killer cell lectin-like receptor subfamily B member 1,28047,888,1.52 [1.26-1.82],7.81542308370226e-06
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,KLRD1,Natural killer cells antigen CD94,28047,888,1.30 [1.13-1.50],0.0003198819893506
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,KLRK1,NKG2-D type II integral membrane protein,24141,733,1.46 [1.22-1.75],4.489564781368021e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,LAG3,Lymphocyte activation gene 3 protein,27636,879,1.34 [1.15-1.56],0.0002074016729585
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,LAMA4,Laminin subunit alpha-4,27898,881,0.78 [0.64-0.95],0.0145786872635054
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,LAMP3,Lysosome-associated membrane glycoprotein 3,28001,887,0.87 [0.77-0.99],0.0313713388288385
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,LDLR,Low-density lipoprotein receptor,27825,879,0.87 [0.77-0.99],0.0324064113304122
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,LEP,Leptin,27761,877,0.89 [0.81-0.99],0.0247711982797504
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,LEPR,Leptin receptor,27761,877,0.80 [0.64-1.00],0.0498627182598029
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,LGALS3BP,Galectin-3-binding protein,24244,735,0.76 [0.58-1.00],0.0489283276479706
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,LIF,Leukemia inhibitory factor,27078,865,0.72 [0.62-0.83],5.972161196126085e-06
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,27716,877,0.80 [0.65-0.99],0.0379403790910647
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,LPL,Lipoprotein lipase,27761,877,0.86 [0.75-0.99],0.0341701584750799
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,LRG1,Leucine-rich alpha-2-glycoprotein,24244,735,0.70 [0.51-0.95],0.0212677363063025
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,23420,709,0.65 [0.48-0.89],0.0078094567207886
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,LRRC38,Leucine-rich repeat-containing protein 38,23520,713,0.84 [0.71-0.99],0.0390678549124681
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,LSP1,Lymphocyte-specific protein 1,27713,881,0.79 [0.67-0.93],0.0037086574381738
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,LTB,Lymphotoxin-beta,24061,735,0.76 [0.60-0.95],0.0186455551381171
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,LY9,T-lymphocyte surface antigen Ly-9,27461,864,1.72 [1.35-2.20],1.0148069491668023e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,LYPLA2,Acyl-protein thioesterase 2,23415,719,0.92 [0.85-0.99],0.0326519755610677
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,LYZL2,Lysozyme-like protein 2,23319,718,0.70 [0.56-0.88],0.001926018692441
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MAMDC4,Apical endosomal glycoprotein,24061,735,0.84 [0.73-0.97],0.0151681089305796
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MANSC1,MANSC domain-containing protein 1,27858,887,0.79 [0.62-0.99],0.0435272072616554
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,23415,719,0.72 [0.57-0.92],0.0084005844306923
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MATN3,Matrilin-3,27523,875,0.78 [0.64-0.95],0.015098045065605
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MCAM,Cell surface glycoprotein MUC18,27854,874,0.77 [0.63-0.93],0.0079543231591247
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MEGF9,Multiple epidermal growth factor-like domains protein 9,28006,885,0.52 [0.39-0.69],4.618781254083937e-06
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MENT,Protein MENT,23684,720,0.66 [0.45-0.96],0.0285187474816119
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MERTK,Tyrosine-protein kinase Mer,28047,888,0.61 [0.48-0.78],6.051917260891883e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MFGE8,Lactadherin,27762,876,0.75 [0.64-0.89],0.000653607785611
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MICALL2,MICAL-like protein 2,23520,713,1.12 [1.00-1.25],0.0478920513913598
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MMP3,Stromelysin-1,27762,876,0.85 [0.74-0.99],0.034700671800462
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MMP8,Neutrophil collagenase,27951,888,0.91 [0.84-1.00],0.0385405121801945
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MMP9,Matrix metalloproteinase-9,27713,875,0.85 [0.77-0.95],0.0024131312780419
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MRC1,Macrophage mannose receptor 1,24209,732,0.68 [0.51-0.91],0.0087460188141729
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MSLN,Mesothelin,27592,879,0.74 [0.65-0.85],1.1334896470419298e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MSMB,Beta-microseminoprotein,27663,877,0.84 [0.76-0.93],0.000867978328935
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24141,733,0.68 [0.49-0.94],0.0192712627853234
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MUC13,Mucin-13,27078,865,0.87 [0.75-1.00],0.0434219931308773
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MVK,Mevalonate kinase,27208,867,0.89 [0.82-0.98],0.0144694423920055
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MYOC,Myocilin,27762,876,0.75 [0.65-0.86],7.669099468783795e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MYOM3,Myomesin-3,23684,720,1.10 [1.01-1.19],0.0288290937856221
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,MZB1,Marginal zone B- and B1-cell-specific protein,27860,881,1.50 [1.31-1.72],3.453371950169921e-09
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,23684,720,0.55 [0.38-0.79],0.0014030816308786
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,NCS1,Neuronal calcium sensor 1,27991,889,0.58 [0.46-0.73],4.003801263347531e-06
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24061,735,0.87 [0.77-0.99],0.0348728554568306
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,23470,710,0.77 [0.61-0.97],0.0257749005074832
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,NECTIN1,Nectin-1,23511,713,0.71 [0.54-0.93],0.0128195934922791
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,NECTIN2,Nectin-2,27716,877,0.71 [0.56-0.91],0.006111819894742
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,NEFL,Neurofilament light polypeptide,26989,862,0.83 [0.71-0.98],0.0274209424505276
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",27208,867,0.79 [0.70-0.89],0.0001664630604716
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,NFKBIE,NF-kappa-B inhibitor epsilon,27107,863,0.85 [0.74-0.98],0.0267549874232982
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,NID1,Nidogen-1,27759,873,0.82 [0.69-0.97],0.0217145241725672
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,NINJ1,Ninjurin-1,27107,863,0.85 [0.75-0.97],0.0142820998491548
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,NME1,Nucleoside diphosphate kinase A,23511,713,0.68 [0.47-1.00],0.0472916708273268
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24158,739,0.88 [0.78-1.00],0.0489764836738249
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,NOTCH2,Neurogenic locus notch homolog protein 2,24196,735,1.48 [1.07-2.06],0.0186546405461783
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,NPDC1,Neural proliferation differentiation and control protein 1,27761,877,0.68 [0.53-0.87],0.0019957715975066
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,NPL,N-acetylneuraminate lyase,24197,736,0.80 [0.66-0.96],0.0183310577253972
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,NPTXR,Neuronal pentraxin receptor,27761,877,0.81 [0.67-0.99],0.040946469329516
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,NRP2,Neuropilin-2,27762,876,0.74 [0.59-0.93],0.0091675179718725
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,NTRK3,NT-3 growth factor receptor,27998,890,0.73 [0.54-0.99],0.0441078635594492
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,OCLN,Occludin,24158,739,0.82 [0.68-0.98],0.0329632489228647
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,OSM,Oncostatin-M,27584,877,0.89 [0.81-0.97],0.0063556612356284
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,OXT,Oxytocin-neurophysin 1,27998,890,0.91 [0.87-0.96],0.0004870587848905
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PAEP,Glycodelin,27565,878,1.10 [1.06-1.14],1.5163810124015209e-06
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24158,739,0.91 [0.85-0.98],0.0176273335900941
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PAMR1,Inactive serine protease PAMR1,27762,876,0.78 [0.62-0.98],0.0363193171713523
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PAPPA,Pappalysin-1,27208,867,1.18 [1.04-1.35],0.0114178518004228
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PCSK9,Proprotein convertase subtilisin/kexin type 9,28096,889,0.78 [0.66-0.92],0.0033922887062802
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PDCD1,Programmed cell death protein 1,27950,889,1.35 [1.16-1.57],8.899437058189926e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PDGFC,Platelet-derived growth factor C,27107,863,0.80 [0.64-1.00],0.0472769913833789
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PDGFRA,Platelet-derived growth factor receptor alpha,27761,877,0.65 [0.51-0.82],0.0003265571178959
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PDIA3,Protein disulfide-isomerase A3,23684,720,0.58 [0.41-0.80],0.0011169880825019
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,23319,718,0.81 [0.69-0.95],0.010199810653542
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PIGR,Polymeric immunoglobulin receptor,27402,870,0.72 [0.60-0.87],0.0007133321903137
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PLA2G1B,Phospholipase A2,28047,882,1.24 [1.05-1.47],0.0097345323670802
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PLAUR,Urokinase plasminogen activator surface receptor,27585,872,0.73 [0.57-0.93],0.0116983399478356
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PNMA1,Paraneoplastic antigen Ma1,23574,720,0.85 [0.74-0.99],0.0379804356693689
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PPL,Periplakin,23511,713,0.73 [0.57-0.95],0.0175587017699332
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PPM1A,Protein phosphatase 1A,27107,863,0.77 [0.62-0.97],0.0270848934327079
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PRAP1,Proline-rich acidic protein 1,24196,735,0.79 [0.66-0.95],0.0106220062692011
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PRCP,Lysosomal Pro-X carboxypeptidase,27925,882,0.74 [0.60-0.92],0.006587318405347
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PRG2,Bone marrow proteoglycan,24196,735,1.27 [1.10-1.46],0.0010277808013657
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PRG3,Proteoglycan 3,24196,735,1.35 [1.17-1.56],6.178102398823499e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,23520,713,0.72 [0.55-0.93],0.013760001800083
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PRL,Prolactin,27998,890,0.70 [0.65-0.77],1.6616613250786301e-15
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PROC,Vitamin K-dependent protein C,27806,874,0.67 [0.52-0.86],0.0018411406519999
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PRSS27,Serine protease 27,27672,873,0.82 [0.70-0.97],0.0169354657821075
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PRSS8,Prostasin,27671,874,0.76 [0.64-0.90],0.0018805372729494
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PSMA1,Proteasome subunit alpha type-1,27107,863,0.82 [0.71-0.95],0.0100616763771481
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PSMC3,26S proteasome regulatory subunit 6A,23319,718,0.74 [0.56-0.96],0.0259753740562602
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PSPN,Persephin,27713,881,0.94 [0.88-0.99],0.0335696021898596
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PTGR1,Prostaglandin reductase 1,24197,736,0.84 [0.76-0.93],0.00099925773667
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PTN,Pleiotrophin,27250,862,0.84 [0.74-0.96],0.0100814441453421
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24197,736,0.59 [0.45-0.77],0.0001067327507563
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PTPRF,Receptor-type tyrosine-protein phosphatase F,28096,889,0.79 [0.63-0.99],0.0409122347871589
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PTPRH,Receptor-type tyrosine-protein phosphatase H,24071,732,1.22 [1.04-1.43],0.0174995503040545
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24071,732,0.68 [0.47-1.00],0.0487959933030734
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24197,736,0.63 [0.49-0.81],0.0003000206793818
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PTS,6-pyruvoyl tetrahydrobiopterin synthase,26957,863,0.87 [0.76-0.99],0.0416967656402167
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PVR,Poliovirus receptor,27998,890,0.80 [0.67-0.96],0.0137986244514832
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PXN,Paxillin,27078,865,0.86 [0.75-0.97],0.0185413090713304
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PYY,Peptide YY,23429,723,0.90 [0.82-0.98],0.0207902060382864
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,PZP,Pregnancy zone protein,24244,735,1.21 [1.10-1.33],0.0001329169893085
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,RABEPK,Rab9 effector protein with kelch motifs,27107,863,0.89 [0.80-0.99],0.0329685988916986
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,RAP1A,Ras-related protein Rap-1A,23511,713,0.84 [0.74-0.95],0.0077260189905808
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,RARRES1,Retinoic acid receptor responder protein 1,27107,863,0.74 [0.59-0.93],0.0083478169693312
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,RARRES2,Retinoic acid receptor responder protein 2,27901,878,0.81 [0.71-0.94],0.0041543994293146
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,RBFOX3,RNA binding protein fox-1 homolog 3,24158,739,0.79 [0.63-0.98],0.0360856513793161
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,RELB,Transcription factor RelB,23511,713,0.79 [0.67-0.93],0.00573792123117
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,REN,Renin,27761,877,0.82 [0.72-0.92],0.0007306746868339
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,RICTOR,Rapamycin-insensitive companion of mTOR,23511,713,1.24 [1.08-1.43],0.0021203433256958
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,RNASE4,Ribonuclease 4,23393,703,0.60 [0.44-0.83],0.0017976416107963
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,RPA2,Replication protein A 32 kDa subunit,23511,713,0.72 [0.55-0.94],0.015425741520636
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,RPGR,X-linked retinitis pigmentosa GTPase regulator,23520,713,0.76 [0.62-0.93],0.0090052096211493
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,RPL14,60S ribosomal protein L14,23574,720,0.74 [0.61-0.91],0.0042789614658513
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,RSPO3,R-spondin-3,27991,889,0.68 [0.54-0.85],0.0010002887042915
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,RTBDN,Retbindin,27636,879,0.76 [0.60-0.96],0.0209567828317887
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,S100A16,Protein S100-A16,27036,865,0.88 [0.78-0.98],0.0221693195876474
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SCARA5,Scavenger receptor class A member 5,27998,890,0.63 [0.50-0.79],6.452310594169914e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SCG2,Secretogranin-2,27854,887,0.72 [0.58-0.90],0.0031549083037934
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SCGB3A2,Secretoglobin family 3A member 2,27850,880,0.86 [0.79-0.95],0.0018011244425445
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SCN2A,Sodium channel protein type 2 subunit alpha,23415,719,0.84 [0.71-1.00],0.0489403797636148
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SCN4B,Sodium channel subunit beta-4,23574,720,0.75 [0.62-0.91],0.0038359753980465
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SDC4,Syndecan-4,27761,877,0.79 [0.68-0.91],0.0012127484753652
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SELL,L-selectin,24244,735,1.72 [1.24-2.40],0.0013435895609963
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SEMA4C,Semaphorin-4C,27636,879,0.71 [0.55-0.92],0.0092507812990092
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SEMA7A,Semaphorin-7A,28006,885,1.40 [1.09-1.79],0.0074280317961428
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SEPTIN8,Septin-8,24094,732,0.76 [0.59-0.96],0.0222988380583901
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SERPINA11,Serpin A11,28096,889,0.83 [0.71-0.97],0.0230200929160748
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SERPINA3,Alpha-1-antichymotrypsin,24144,734,0.44 [0.25-0.78],0.0049160483366374
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SERPINA9,Serpin A9,27492,875,1.17 [1.08-1.28],0.0002735764778828
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SERPINB5,Serpin B5,27250,862,1.19 [1.03-1.36],0.0142978558725438
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SERPIND1,Heparin cofactor 2,24192,734,0.70 [0.53-0.93],0.0138579480927494
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SERPINF1,Pigment epithelium-derived factor,23878,723,0.65 [0.47-0.89],0.0077625144417964
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SERPING1,Plasma protease C1 inhibitor,24192,734,0.51 [0.34-0.76],0.0010775248117079
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SFRP1,Secreted frizzled-related protein 1,27483,870,0.73 [0.62-0.85],7.056052220388138e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SFTPA1,Pulmonary surfactant-associated protein A1,27107,863,0.86 [0.76-0.97],0.0177352423505831
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SFTPA2,Pulmonary surfactant-associated protein A2,27107,863,0.83 [0.73-0.96],0.0089628080411913
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SH2D1A,SH2 domain-containing protein 1A,27713,881,1.12 [1.00-1.26],0.0438526885624631
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SIGLEC7,Sialic acid-binding Ig-like lectin 7,27761,877,0.63 [0.50-0.80],0.0001362000299018
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SIL1,Nucleotide exchange factor SIL1,23574,720,1.25 [1.01-1.54],0.0410964612181427
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SLAMF7,SLAM family member 7,27713,881,1.15 [1.03-1.29],0.0169638647224277
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SLC44A4,Choline transporter-like protein 4,23520,713,1.12 [1.01-1.25],0.0323762616417677
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SMAD5,Mothers against decapentaplegic homolog 5,27636,879,0.60 [0.45-0.80],0.0004363426465149
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SMOC1,SPARC-related modular calcium-binding protein 1,27991,889,0.70 [0.57-0.85],0.0003705298077027
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SMOC2,SPARC-related modular calcium-binding protein 2,27898,881,0.63 [0.53-0.76],4.066170210216211e-07
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SOST,Sclerostin,27716,877,0.69 [0.58-0.82],1.7644573146332887e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SPINK5,Serine protease inhibitor Kazal-type 5,27762,876,0.77 [0.63-0.94],0.0113217333474035
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SPINT1,Kunitz-type protease inhibitor 1,27681,875,0.75 [0.57-0.98],0.0375766348714822
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SPOCK1,Testican-1,27565,878,0.69 [0.53-0.90],0.0069945225746591
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SPON1,Spondin-1,27812,880,0.69 [0.56-0.85],0.000455379341984
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SPON2,Spondin-2,27629,875,0.78 [0.63-0.95],0.0140908319248903
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SPP1,Osteopontin,28049,886,0.76 [0.66-0.88],0.0001326073074861
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SPRR3,Small proline-rich protein 3,24141,733,0.87 [0.77-0.98],0.0247350961934104
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SRP14,Signal recognition particle 14 kDa protein,27636,879,0.87 [0.79-0.97],0.0137104633316949
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",23511,713,0.77 [0.61-0.98],0.0347134757231327
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,27854,874,0.67 [0.57-0.78],4.893432784455915e-07
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",28096,889,0.78 [0.62-0.98],0.0329582075826517
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SULT2A1,Bile salt sulfotransferase,27713,881,0.83 [0.73-0.95],0.0064973666693219
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SUOX,"Sulfite oxidase, mitochondrial",24158,739,0.84 [0.74-0.96],0.0105855772412902
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,SUSD2,Sushi domain-containing protein 2,27762,876,0.75 [0.60-0.95],0.0183894717747737
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TAFA5,Chemokine-like protein TAFA-5,27636,879,0.77 [0.63-0.93],0.0080322814846148
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TCL1A,T-cell leukemia/lymphoma protein 1A,27519,877,0.84 [0.78-0.91],3.9098029737601146e-06
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TCTN3,Tectonic-3,24197,736,0.67 [0.51-0.88],0.0039381841410984
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TDO2,"Tryptophan 2,3-dioxygenase",23520,713,0.74 [0.58-0.94],0.0144360645731724
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TERF1,Telomeric repeat-binding factor 1,23511,713,0.73 [0.55-0.97],0.0308676839291587
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TET2,Methylcytosine dioxygenase TET2,23697,722,1.08 [1.01-1.17],0.0299881237724028
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TEX33,Testis-expressed protein 33,23743,724,1.20 [1.02-1.41],0.0271687809707539
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TFF1,Trefoil factor 1,27622,875,0.88 [0.80-0.97],0.0098651614097759
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TFF3,Trefoil factor 3,27718,870,0.89 [0.80-0.98],0.0184909193405434
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TFPI,Tissue factor pathway inhibitor,27669,869,0.65 [0.52-0.81],0.0001017805943411
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TG,Thyroglobulin,24061,735,1.09 [1.02-1.17],0.0128643079544797
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TGFBI,Transforming growth factor-beta-induced protein ig-h3,27579,866,0.73 [0.57-0.93],0.0106302199368276
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,THBS4,Thrombospondin-4,27759,873,0.78 [0.67-0.90],0.0007019558430541
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,THPO,Thrombopoietin,27250,862,0.79 [0.66-0.94],0.0084789598731414
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,THY1,Thy-1 membrane glycoprotein,27998,890,0.76 [0.59-0.98],0.0350609035049054
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,23743,724,1.26 [1.04-1.53],0.0189817570259742
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TIMP4,Metalloproteinase inhibitor 4,27762,876,0.75 [0.63-0.89],0.0009655819257802
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TK1,"Thymidine kinase, cytosolic",23743,724,0.81 [0.68-0.97],0.0191378967925669
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TMPRSS15,Enteropeptidase,27636,879,0.90 [0.84-0.97],0.0035709920388072
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,27565,878,0.80 [0.64-1.00],0.0464827315170752
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,27813,877,0.87 [0.76-0.99],0.0337069654461495
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,27763,878,0.77 [0.62-0.95],0.0142616223365103
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,27858,887,0.76 [0.62-0.93],0.0080152000811637
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,27812,880,1.29 [1.05-1.58],0.0143764069402187
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,23684,720,1.64 [1.33-2.03],4.3392605754521495e-06
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,27991,889,0.79 [0.62-1.00],0.0485072569341673
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,27998,890,1.23 [1.07-1.41],0.0031296730067079
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TNFSF11,Tumor necrosis factor ligand superfamily member 11,27713,881,1.15 [1.04-1.28],0.0072331455094691
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TNFSF13,Tumor necrosis factor ligand superfamily member 13,27898,881,0.49 [0.38-0.64],3.715336665013669e-08
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,28049,888,0.69 [0.54-0.88],0.0028221276673009
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TNN,Tenascin-N,24196,735,1.25 [1.05-1.49],0.011312996316559
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TREM2,Triggering receptor expressed on myeloid cells 2,27763,878,0.86 [0.76-0.98],0.0277928783582465
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TREML2,Trem-like transcript 2 protein,27762,876,1.23 [1.01-1.49],0.0382764058079459
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TSHB,Thyrotropin subunit beta,27761,877,0.90 [0.83-0.98],0.0203835845858127
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TSPAN1,Tetraspanin-1,27250,862,0.77 [0.63-0.94],0.0090167516107256
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TSPAN8,Tetraspanin-8,24071,732,0.90 [0.83-0.97],0.007819533153775
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TXNDC15,Thioredoxin domain-containing protein 15,27858,887,0.78 [0.62-0.99],0.0435277157545179
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,TYRO3,Tyrosine-protein kinase receptor TYRO3,27761,877,0.69 [0.54-0.87],0.0014521725611611
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,UGDH,UDP-glucose 6-dehydrogenase,23429,723,0.88 [0.80-0.96],0.0045643130191852
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,UHRF2,E3 ubiquitin-protein ligase UHRF2,23429,723,0.79 [0.63-1.00],0.0464747073851946
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,ULBP2,UL16-binding protein 2,27565,878,0.82 [0.68-0.99],0.0418200609342785
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,UPB1,Beta-ureidopropionase,24197,736,0.91 [0.83-0.99],0.0229936665813318
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,VASN,Vasorin,27311,853,0.75 [0.58-0.95],0.0193157223801992
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,VCAM1,Vascular cell adhesion protein 1,27806,874,1.39 [1.09-1.78],0.0086803548520369
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,VCPKMT,Protein-lysine methyltransferase METTL21D,23319,718,0.91 [0.82-1.00],0.0440406991499526
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,VEGFA,Vascular endothelial growth factor A,27953,884,0.89 [0.79-1.00],0.0453377859076914
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,VGF,Neurosecretory protein VGF,24158,739,0.74 [0.57-0.97],0.0294384399212436
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,VIPR1,Vasoactive intestinal polypeptide receptor 1,23574,720,0.72 [0.53-0.99],0.0461157136123932
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,VIT,Vitrin,24197,736,0.60 [0.49-0.74],2.4035254549649664e-06
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,VNN2,Vascular non-inflammatory molecule 2,27636,879,0.78 [0.68-0.89],0.0003206729788525
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,VSNL1,Visinin-like protein 1,24141,733,0.74 [0.58-0.93],0.0101387441147871
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,VSTM2B,V-set and transmembrane domain-containing protein 2B,23743,724,0.74 [0.59-0.92],0.0077620911725586
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,27250,862,0.88 [0.78-0.99],0.0389459285416071
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,VWA1,von Willebrand factor A domain-containing protein 1,27942,889,0.73 [0.63-0.85],4.665682784644451e-05
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,VWC2,Brorin,27471,874,0.78 [0.65-0.92],0.0042536923597178
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,WASL,Neural Wiskott-Aldrich syndrome protein,23511,713,0.83 [0.72-0.95],0.0091198345715447
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,WIF1,Wnt inhibitory factor 1,27991,889,0.82 [0.68-1.00],0.0448932915284555
"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,WNT9A,Protein Wnt-9a,27208,867,0.69 [0.54-0.89],0.0036688308290815
